Nuclear Medicine and Biology
Volume 35, Issue 7 , Pages 801-804 , October 2008

Hydroxytyrosol increases norepinephrine transporter function in pheochromocytoma cells

  • Berta Luzón-Toro

      Affiliations

    • Institute of Parasitology and Biomedicine “López-Neyra”, Spanish National Research Council (CSIC), 18100 Granada, Spain
    • ,
  • Arjan Geerlings

      Affiliations

    • Puleva Biotech, 18004 Granada, Spain
    • ,
  • Sabine Hilfiker

      Affiliations

    • Institute of Parasitology and Biomedicine “López-Neyra”, Spanish National Research Council (CSIC), 18100 Granada, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 958 181654; fax: +34 958 181632.

Received 10 July 2008 ,Accepted 24 July 2008.

References 

  1. Phillips JK, Dubey R, Sesiashvilvi E, Takeda M, Christie DL, Lipski J. Differential expression of the noradrenaline transporter in adrenergic chromaffin cells, ganglion cells and nerve fibers of the rat adrenal medulla. J Chem Neuroanat. 2001;21:95–104
  2. Cleary S, Brouwers FM, Eisenhofer G, Pacak K, Christie DL, Lipski J, et al. Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase in normal human adrenal gland and phaeochromocytoma. Cell Tissue Res. 2005;322:443–453
  3. Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2007;14:569–585
  4. Scholz T, Eisenhofer G, Pacak K, Dralle H, Lehnert H. Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab. 2007;4:1217–1225
  5. Cleary S, Phillips JK. The norepinephrine transporter and pheochromocytoma. Ann N Y Acad Sci. 2006;1073:263–269
  6. Loh KC, Fitzgerald PA, Matthay KK, Yeo PP, Price DC. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported cases. J Endocrinol Invest. 1997;20:648–658
  7. Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman JM, Leight GS, et al. Iodine-131 metaiodobenzylguanidinee is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery. 2003;134:956–962
  8. Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman J, Onaitis MW, et al. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid: results in 98 patients. Cancer. 2004;101:470–476
  9. Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, et al. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Ann N Y Acad Sci. 2006;1073:465–490
  10. Armour A, Cunningham SH, Gaze MN, Wheldon TE, Mairs RJ. The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro. Br J Cancer. 1997;75:470–476
  11. Meco D, Lasorella A, Riccardi A, Servidei T, Mastrangelo R, Riccardi R. Influence of cisplatin and doxorubicin on 125I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines. Eur J Cancer. 1999;35:1227–1234
  12. Mastrangelo S, Tornesello A, Diociaiuti L, Pession A, Prete A, Rufini V, et al. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer. 2001;84:460–466
  13. Hara K, Minami K, Ueno S, Toyohira Y, Tsutsui M, Shigematsu A, et al. Up-regulation of noradrenaline transporter in response to prolonged exposure to ketamine. Naunyn-Schmiedeberg's Arch Pharmacol. 2002;365:406–412
  14. McCluskey AG, Boyd M, Ross SC, Cosimo E, Clark AM, Angerson WJ, et al. [131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter. Clin Cancer Res. 2005;11:7929–7937
  15. Visioli F, Borsani L, Galli C. Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res. 2000;47:419–425
  16. De la Puerta R, Martínez Domínguez ME, Ruíz-Gutíerrez V, Flavill JA, Hoult JR. Effects of virgin olive oil phenolics on scavenging of reactive nitrogen species and upon nitrergic neurotransmission. Life Sci. 2001;69:1213–1222
  17. Mao W, Iwai C, Qin F, Liang C. Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress. Am J Physiol Heart Circ Physiol. 2005;288:H2381–H2389
  18. González-Santiago M, Martín-Bautista E, Carrero JJ, Fonollá J, Baró L, Bartolomé MV, et al. One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis. 2006;188:35–42
  19. Rajebhosale M, Greenwood S, Vidugiriene J, Jeromin A, Hilfiker S. Phosphatidylinositol 4-OH kinase is a downstream target of neuronal calcium sensor 1 in enhancing exocytosis in neuroendocrine cells. J Biol Chem. 2003;278:6075–6084
  20. Fdez E, Jowitt TA, Wang MC, Rajebhosale M, Foster K, Bella J, et al. A role for SNARE complex dimerization during neurosecretion. Mol Biol Cell. 2008;19:3379–3389
  21. Bonanome A, Pagnan A, Caruso D, Toia A, Xamin A, Fedeli E, et al. Evidence of postprandial absorption of olive oil phenols in humans. Nutr Metab Cardiovasc Dis. 2000;10:111–120
  22. D'Angelo S, Manna C, Migliardi V, Mazzoni O, Morrica P, Capasso G, et al. Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. Drug Metab Dispos. 2001;29:1492–1498

PII: S0969-8051(08)00174-1

doi: 10.1016/j.nucmedbio.2008.07.005

Nuclear Medicine and Biology
Volume 35, Issue 7 , Pages 801-804 , October 2008

Article Tools

* Image Usage & Resolution